A study from the Keck School of Medicine of USC finds that a peptide only found in Old World monkeys has the potential to stop rheumatoid arthritis progression better than established treatments
In the quest for a new and more effective treatment for rheumatoid arthritis, researchers from the Keck School of Medicine of USC looked to a primate that mostly roams the land in Asia, the Middle East and Africa. It was a particular peptide only found in Old World monkeys, called ?-defensin 1 (RTD-1), that the researchers believed had the potential to stop — or even reverse — the progression of rheumatoid arthritis, an autoimmune disease that affects about 1.5 million people in the United States. The promising results of their study were published today in PLOS ONE.
“RTD-1 is the prototype of a family of small cyclic peptides (?-defensins), the only circular proteins in the animal kingdom,” says study author Michael Selsted, MD, PhD, chair and professor of pathology at the Keck School. “Previous studies have shown that RTD-1 modulates lethal inflammation in animal models of infection, and we predicted that RTD-1’s protective mechanism in those models would translate to rheumatoid arthritis, a disease in which chronic inflammation produces irreversible joint damage.”
To test their hypothesis, the researchers administered RTD-1 to rats with arthritis for 11 days and observed whether the treatment had any anti-arthritic effects. Within 24 hours of the first administered dose, RTD-1 had significantly reduced arthritis progression. At the end of the treatment, rats that received RTD-1 also had markedly lower arthritis severity scores as compared with rats that had not received RTD-1.
Next, RTD-1 was tested in rats with severe arthritis. The research team found that RTD-1 produced a rapid reduction in arthritis severity within 48 hours of treatment, with complete resolution of clinical disease in all treated rats by day 15.
RTD-1 was then compared to two gold standard treatments for rheumatoid arthritis — methotrexate and etanercept — in rats with severe arthritis. The team found that RTD-1 treatment resulted in greater disease resolution than methotrexate or etanercept. RTD-1 also achieved the highest rate of complete disease resolution of the three treatments.
“Since most available rheumatoid arthritis therapies achieve mild to moderate improvements, and disease remission is rare, there’s a continuing search for new therapeutics,” Selsted says. “Our findings strongly suggest that RTD-1 has potential as a completely new agent for treating rheumatoid arthritis. RTD-1-like molecules may also be effective in the treatment of other inflammatory diseases and cancer.”
Learn more: Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
The Latest on: RTD-1
[google_news title=”” keyword=”RTD-1″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Appeals court agrees RTD not responsible for $111.5 million in costs from faulty rail line rollouton May 14, 2024 at 2:18 am
Colorado's second-highest court agreed on Thursday that the contractor responsible for building and operating the recent expansion of the Regional Transportation District's rail network cannot recover ...
- RTD's Doctor Who Has Now Referenced Chibnall's Timeless Child In 5 Out Of 6 Episodes So Faron May 13, 2024 at 1:20 pm
The newest episodes of Doctor Who have confirmed the Timeless Child's place in the franchise canon, teasing its continued importance.
- Doctor Who Season 14's Great First 2 Episodes Cover Up A Bigger Problem RTD Must Addresson May 12, 2024 at 8:40 am
Doctor Who season 14's first two episodes represent a strong start for Ncuti Gatwa, but they cover up a bigger problem waiting in RTD's future.
- Teen arrested, accused of threatening RTD passengers with airsoft gunon May 9, 2024 at 5:01 pm
A 19-year-old is in police custody and facing several charges after allegedly threatening people at a Lakewood RTD station with an airsoft gun.
- High Noon Levels Up the RTD Category with the Release of High Noon Vodka Iced Teaon May 6, 2024 at 7:43 am
Spirit of Gallo's High Noon, the #1 spirits brand by volume**, is launching High Noon Vodka Iced Tea, made with real vodka, real iced tea, and no added sugar. Now available on shelves nationwide, High ...
- RTD Beverages Market to Reach $1,582.7 Billion by 2031 - Exclusive Report by Meticulous Research®on May 6, 2024 at 3:11 am
REDDING, Calif., May 6, 2024 /PRNewswire/ -- According to a new market research report titled, "RTD Beverages Market By Product Type (Alcoholic and Non-alcoholic [Flavored, Tea, Coffee ...
- A short history of Colorado lawmakers’ magical thinking on RTD reformon April 24, 2024 at 5:00 pm
RTD’s lower operational costs on its privatize ... rail service by raising the district’s sales tax from 0.6% to 1% — RTD’s operating expenditures have, at best, barely kept pace with ...
- Crashes and Disasterson April 18, 2024 at 12:13 am
The crash happened around 1 p.m. at the intersection of Stout and 15th streets in Denver, RTD spokesperson Tina Jaquez said. No light rail customers or operators were injured in the crash.
- RTD train crashes with vehicle in downtown Denver, several routes adjustedon April 17, 2024 at 1:40 pm
RTD said the incident happened around 1:40 p.m. There had been no reports of injuries to customers or the operator on the train as of 2 p.m., according to RTD. Denver police say the driver was ...
- Colorado Newson April 12, 2024 at 11:03 pm
RTD directors expressed skepticism this week over ... 2,342 square-mile area on an $888 million budget drawn mostly from a 1%t sales tax. “They would do a worse job. They are not as connected ...
via Google News and Bing News